SG10201807682PA - Methods of Treating or Preventing Respiratory Conditions - Google Patents

Methods of Treating or Preventing Respiratory Conditions

Info

Publication number
SG10201807682PA
SG10201807682PA SG10201807682PA SG10201807682PA SG10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA
Authority
SG
Singapore
Prior art keywords
treating
respiratory
methods
subject
preventing respiratory
Prior art date
Application number
SG10201807682PA
Other languages
English (en)
Inventor
Ravi Krishnan
Peter Ghosh
Silviu Itescu
Original Assignee
Mesoblast Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mesoblast Inc filed Critical Mesoblast Inc
Publication of SG10201807682PA publication Critical patent/SG10201807682PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG10201807682PA 2012-12-12 2013-12-12 Methods of Treating or Preventing Respiratory Conditions SG10201807682PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12

Publications (1)

Publication Number Publication Date
SG10201807682PA true SG10201807682PA (en) 2018-10-30

Family

ID=50933587

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201807682PA SG10201807682PA (en) 2012-12-12 2013-12-12 Methods of Treating or Preventing Respiratory Conditions
SG11201504352TA SG11201504352TA (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201504352TA SG11201504352TA (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Country Status (11)

Country Link
US (3) US10028979B2 (enExample)
EP (1) EP2931373B1 (enExample)
JP (5) JP6313327B2 (enExample)
KR (1) KR101748712B1 (enExample)
CN (2) CN115919901A (enExample)
AU (4) AU2013360026B2 (enExample)
CA (1) CA2893951C (enExample)
ES (1) ES2759281T3 (enExample)
IL (1) IL239309A0 (enExample)
SG (2) SG10201807682PA (enExample)
WO (1) WO2014089625A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2931373B1 (en) 2012-12-12 2019-08-21 Mesoblast, Inc. Methods of treating or preventing respiratory conditions
WO2016049156A1 (en) * 2014-09-23 2016-03-31 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
BR112020004856A2 (pt) * 2017-09-15 2020-09-15 Cynata Therapeutics Limited método para tratar doença alérgica das vias aéreas (aad)/asma
US20230086254A1 (en) * 2020-01-30 2023-03-23 Jcr Pharmaceuticals Co., Ltd. Medicinal composition comprising dental pulp-derived cells
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
DE60314602T2 (de) * 2002-02-19 2008-02-28 Medipost, Co., Ltd. Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
US20080260694A1 (en) * 2004-09-24 2008-10-23 Angioblast Systems, Inc. Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof
KR101617319B1 (ko) * 2005-04-12 2016-05-02 메소블라스트, 아이엔씨. 조직 비특이적인 알카리 포스파타제에 의한 다분화성 성체 세포의 분리
US20120269774A1 (en) * 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
ES2923016T3 (es) * 2007-08-06 2022-09-22 Mesoblast Inc Células precursoras mesenquimales TNAP+ para el tratamiento de enfermedades del tejido conectivo
JP5539886B2 (ja) * 2007-10-17 2014-07-02 ティクセル Ｔｒ１細胞、間葉系幹細胞およびその使用
CN102144028B (zh) * 2008-09-03 2017-12-26 中胚有限公司 造血前体的扩增
KR101871472B1 (ko) * 2010-07-02 2018-06-27 메소블라스트, 아이엔씨. 이식편대숙주 질환의 치료 방법
CN109432126B (zh) * 2011-03-11 2022-06-14 儿童医学中心公司 与间充质干细胞外来体相关的方法和组合物
CN109276706A (zh) * 2011-06-03 2019-01-29 麦瑟布莱斯特公司 治疗或预防神经性疾病的方法
EP2931373B1 (en) 2012-12-12 2019-08-21 Mesoblast, Inc. Methods of treating or preventing respiratory conditions

Also Published As

Publication number Publication date
JP2024041904A (ja) 2024-03-27
US10028979B2 (en) 2018-07-24
CA2893951A1 (en) 2014-06-19
US20200289578A1 (en) 2020-09-17
AU2020202022A1 (en) 2020-04-09
JP2020097618A (ja) 2020-06-25
CA2893951C (en) 2022-05-03
JP6665218B2 (ja) 2020-03-13
AU2022209219B2 (en) 2025-08-14
US20190046575A1 (en) 2019-02-14
US10688134B2 (en) 2020-06-23
JP2022065132A (ja) 2022-04-26
IL239309A0 (en) 2015-07-30
AU2022209219A1 (en) 2022-08-18
US20150306146A1 (en) 2015-10-29
WO2014089625A1 (en) 2014-06-19
JP2018118987A (ja) 2018-08-02
EP2931373A1 (en) 2015-10-21
EP2931373A4 (en) 2016-05-04
JP2016502980A (ja) 2016-02-01
CN115919901A (zh) 2023-04-07
AU2018226514A1 (en) 2018-09-27
AU2013360026B2 (en) 2018-06-21
AU2013360026A1 (en) 2015-07-02
CN105377274A (zh) 2016-03-02
ES2759281T3 (es) 2020-05-08
SG11201504352TA (en) 2015-07-30
AU2018226514B2 (en) 2020-01-02
HK1210077A1 (en) 2016-04-15
JP7420844B2 (ja) 2024-01-23
EP2931373B1 (en) 2019-08-21
JP6313327B2 (ja) 2018-04-18
KR101748712B1 (ko) 2017-06-19
KR20150090237A (ko) 2015-08-05

Similar Documents

Publication Publication Date Title
SG10201807682PA (en) Methods of Treating or Preventing Respiratory Conditions
BR112013011827A2 (pt) ''respirador com peça facial filtrante que tem uma vedação facial moldada com sobreposição''
BR112013011108A2 (pt) ''respirador de peça facial filtrante que tem uma estrutura de suporte moldada por injeção á estrutura filtrante''
IL221873A (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
EP2528934A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
NZ778131A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
MX337437B (es) Composiciones topicas para conservador o restaurar la integridad de la mucosa.
EP2793993A4 (en) RECOVERY AND PROCESSING OF HUMAN IN VIVO EMBRYOS
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
IL248880B (en) Preparations containing r-g-cysteic acid peptides and their uses for the treatment of eye diseases
MX2013000675A (es) Metodo para identificar a un paciente con incrementada probabilidad de responder a una terapia anticancer.
EA019744B9 (ru) Изотиазолилоксифениламидины и их применение для борьбы с фитопатогенными грибами и семенной материал, обработанный изотиазолилоксифениламидинами
SMT201900022T1 (it) Anticorpi umani contro gfr 3 e metodi d’uso di questi
PH12012502406A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
SG195110A1 (en) Pirfenidone and anti-fibrotic therapy in selected patients
PH12013502149A1 (en) Modified acid alpha glucosidase with accelerated processing
MX2016009306A (es) Reequilibrado inmunologico epicutaneo.
IL234101B (en) Preparations containing acamprosate and baclofen for use in the treatment of Parkinson's disease
WO2012047951A3 (en) Human lung stem cells and uses thereof
IN2014CN00795A (enExample)
MX363507B (es) Metodos para administrar óxido nítrico a la sangre arterial o arterializada.
NZ602380A (en) Peptides for vaccine against birch allergy
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
MX2011008179A (es) Peptidos para vacuna.
EP2582392A4 (en) USE OF ANTAGONISTS OF A LYMPHOCYTE B STIMULATING PROTEIN FOR THE TREATMENT OF ASTHMA AND OTHER ALLERGIC AND INFLAMMATORY DISEASES OF THE RESPIRATORY SYSTEM